Ardelyx, Inc. Profile Avatar - Palmy Investing

Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which h…

Biotechnology
US, Waltham [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Ardelyx, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Ardelyx, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Ardelyx, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ARDX's Analysis
CIK: 1437402 CUSIP: 039697107 ISIN: US0396971071 LEI: - UEI: -
Secondary Listings
ARDX has no secondary listings inside our databases.